Quest Diagnostics receives FDA authorization to perform sample pooling for COVID-19 testing

The U.S. Food and Drug Administration reissued an emergency use authorization (EUA) to Quest Diagnostics to authorize its Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under observation. The Quest test is the first COVID-19 diagnostic test to be authorized for use with pooled samples. Sample pooling [...]

The post Quest Diagnostics receives FDA authorization to perform sample pooling for COVID-19 testing appeared first on Outbreak News Today.